Cell-Mediated Immunity Against Antigenically Drifted Influenza A(H3N2) Viruses in Children during a Vaccine Mismatch Season

Journal of Infectious Diseases

Volumn 214, Issue 7, 2016, Pages 1030-1038

  Kim, Jin Hyang ^a   Mishina, Margarita ^b   Chung, Jessie R ^c   Cole, Kelly Stefano ^d,e   Nowalk, Mary Patricia ^d   Martin, Judith M ^f,g   Spencer, Sarah ^c   Flannery, Brendan ^a   Zimmerman, Richard K ^d   Sambhara, Suryaprakash ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

^c ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^d Department of Immunology ^*  (United States)

^e Center for Vaccine Research   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

A(H3N2) drifted viruses; antigenic mismatch; cell mediated immunity; influenza vaccines; young and adolescent children

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR;

ADOLESCENT; AGE DISTRIBUTION; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INFLUENZA A VIRUS (H3N2); MALE; MEMORY CELL; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMABLAST; POST HOC ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEASON; VACCINATION; VACCINE MISMATCH SEASON; VIRUS STRAIN; B LYMPHOCYTE; GENETIC DRIFT; GENETICS; HETEROLOGOUS IMMUNITY; IMMUNOLOGY; INFLUENZA; T LYMPHOCYTE; VIROLOGY;

ADOLESCENT; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; FEMALE; GENETIC DRIFT; HUMANS; IMMUNITY, HETEROLOGOUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MALE; T-LYMPHOCYTES;

EID: 84994127955     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw311     Document Type: Article

References (34)

1. Mullooly JP, Barker WH. Impact of type A influenza on children: a retrospective study. Am J Public Health 1982; 72:1008-16.
2. Longini IM Jr., Koopman JS, Monto AS, Fox JP. Estimating household and community transmission parameters for influenza. Am J Epidemiol 1982; 115:736-51.
3. Hall CB, Douglas RG Jr., Geiman JM, Meagher MP. Viral shedding patterns of children with influenza B infection. J Infect Dis 1979; 140:610-3.
4. Foy HM, Cooney MK, Allan ID, Albrecht JK. Influenza B in households: virus shedding without symptoms or antibody response. Am J Epidemiol 1987; 126:506-15.
5. Pebody RG, Green HK, Andrews N, et al. Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15. Euro Surveill 2015; 20:pii=30029.
6. Thorrington D, Jit M, Eames K. Targeted vaccination in healthy school children-Can primary school vaccination alone control influenza? Vaccine 2015; 33:5415-24.
7. Coudeville L, Bailleux F, Riche B, Megas F, Andre P, Ecochard R. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med Res Methodol 2010; 10:18.
8. Black S, Nicolay U, Vesikari T, et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J 2011; 30:1081-5.
9. Forrest BD, PrideMW, Dunning AJ, et al. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol 2008; 15:1042-53.
10. Centers for Disease Control and Prevention. Past weekly surveillance reports. 2015. http://wwwcdcgov/flu/weekly/pastreports.htm. Accessed 15 June 2016.
11. Flannery B, Clippard J, Zimmerman RK, et al. Early estimates of seasonal influenza vaccine effectiveness-United States, January 2015. MMWR Morb Mortal Wkly Rep 2015; 64:10-5.
12. Flannery B, Clippard J. End-of-season influenza vaccine effectiveness estimates for the 2014-15 season: US Influenza Vaccine Effectiveness (Flu VE) Network. Presented at: CDC Advisory Committee on Immunization Practices Meeting, Atlanta, Georgia, 24 June 2015. http://wwwcdcgov/vaccines/acip/meetings/downloads/ slides-2015-06/flu-02-flannery.pdf. Accessed 15 June 2016.
13. Levine MZ, Martin JM, Gross FL, et al. Neutralizing antibody responses to antigenically drifted influenza A(H3N2) viruses among children and adolescents following 2014-2015 inactivated and live attenuated influenza vaccination. Clin Vaccine Immunol 2016;pii:CVI.00297-16.
14. Wottawa A, Klein G, Altmann H. A method for the isolation of human and animal lymphocytes with Ficoll-Urografin [author's translation]. Wien Klin Wochenschr 1974; 86:161-3.
15. Reber AJ, Kim JH, Biber R, et al. preexisting immunity, more than aging, influences influenza vaccine responses. Open Forum Infect Dis 2015; 2:ofv052.
16. Wrammert J, Koutsonanos D, Li GM, et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 2011; 208:181-93.
17. Andrews SF, Huang Y, Kaur K, et al. Immune history profoundly affects broadly protective B cell responses to influenza. Sci Transl Med 2015; 7:316ra192.
18. Locci M, Havenar-Daughton C, Landais E, et al. Human circulating PD-1-+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 2013; 39:758-69.
19. He J, Tsai LM, Leong YA, et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5 (+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 2013; 39:770-81.
20. Bentebibel SE, Lopez S, Obermoser G, et al. Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci Transl Med 2013; 5:176ra32.
21. Beebe DP, Schreiber RD, Cooper NR. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement. J Immunol 1983; 130:1317-22.
22. Laidlaw BJ, Decman V, Ali MA, et al. Cooperativity between CD8+ T cells, nonneutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity. PLoS Pathog 2013; 9:e1003207.
23. Kim JH, Liepkalns J, Reber AJ, et al. Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains. Vaccine 2016; 34:495-502.
24. Grant E, Wu C, Chan KF, et al. Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses. Immunol Cell Biol 2013; 91:184-94.
25. Assarsson E, Bui HH, Sidney J, et al. Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J Virol 2008; 82:12241-51.
26. Lee LY, Ha do LA, Simmons C, et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 2008; 118:3478-90.
27. Greenbaum JA, Kotturi MF, Kim Y, et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 2009; 106:20365-70.
28. McMichael AJ, Gotch FM, Noble GR, Beare PA. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983; 309:13-7.
29. Wilkinson TM, Li CK, Chui CS, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 2012; 18:274-80.
30. He XS, Holmes TH, Zhang C, et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 2006; 80:11756-66.
31. Zeman AM, Holmes TH, Stamatis S, et al. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine. Pediatr Infect Dis J 2007; 26:107-15.
32. van den Biggelaar AH, Richmond PC, Pomat WS, et al. Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: a randomized controlled trial in Papua New Guinea. Vaccine 2009; 27:1340-7.
33. Rowe J, Macaubas C, Monger TM, et al. Antigen-specific responses to diphtheriatetanus-acellular pertussis vaccine in human infants are initially Th2 polarized. Infect Immun 2000; 68:3873-7.
34. Jakobsen H, Hannesdottir S, Bjarnarson SP, et al. Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharidespecific antibody response and protective efficacy. Eur J Immunol 2006; 36:287-95.